Literature DB >> 34780280

CC16 Deficiency in the Context of Early-Life Mycoplasma pneumoniae Infection Results in Augmented Airway Responses in Adult Mice.

Natalie Iannuzo1, Michael Insel2, Craig Marshall2, William P Pederson3, Kenneth J Addison3, Francesca Polverino2,3, Stefano Guerra2,3, Julie G Ledford1,2,3.   

Abstract

Studies have shown that club cell secretory protein (CC16) plays important protective roles in the lungs, yet its complete biological functions are unclear. We devised a translational mouse model in order to investigate the impact of early life infections, in the context of CC16 deficiency, on lung function in adult mice. CC16 sufficient (WT) and deficient (CC16-/-) mice were infected with Mycoplasma pneumoniae (Mp) as weanlings and assessed as adults (early life infection model; ELIM) and compared to adult mice infected for only 3 days (adult infection model; AIM). CC16-/- Mp-infected mice had significantly increased airway hyperresponsiveness (AHR) in both models compared to WT mice. However, CC16-/- mice infected in early life (ELIM) displayed significantly increased AHR compared to CC16-/- mice infected in adulthood (AIM). In stark contrast, lung function in ELIM WT mice returned to levels similar to saline-treated controls. While WT mice cleared Mp infection in the ELIM, CC16-/- mice remained colonized with Mp throughout the model, which likely contributed to increased airway remodeling and persistence of Muc5ac expression. When CC16-/- mouse tracheal epithelial cells (MTECs) were infected with Mp, increased Mp colonization and collagen gene expression were also detected compared to WT cells, suggesting that CC16 plays a protective role during Mp infection, in part through epithelial-driven host defense mechanisms.

Entities:  

Keywords:  CC16; Mycoplasma pneumoniae; airway remodeling; epithelial cells; inflammation; lung infection

Mesh:

Year:  2021        PMID: 34780280      PMCID: PMC8853681          DOI: 10.1128/IAI.00548-21

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  29 in total

1.  Trajectories and Early Determinants of Circulating CC16 from Birth to Age 32 Years.

Authors:  Jing Zhai; Debra A Stern; Duane L Sherrill; Amber L Spangenberg; Anne L Wright; Wayne J Morgan; Marilyn Halonen; Fernando D Martinez; Stefano Guerra
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

2.  CC16 Binding to α4β1 Integrin Protects against Mycoplasma pneumoniae Infection.

Authors:  Michael D L Johnson; Usir S Younis; Sanjay V Menghani; Kenneth J Addison; Michael Whalen; Aprile L Pilon; Anne E Cress; Francesca Polverino; Casey E Romanoski; Monica Kraft; Fernando D Martinez; Stefano Guerra; Julie G Ledford
Journal:  Am J Respir Crit Care Med       Date:  2021-06-01       Impact factor: 21.405

Review 3.  Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease.

Authors:  A L Pilon
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

4.  Protective role for club cell secretory protein-16 (CC16) in the development of COPD.

Authors:  Maria E Laucho-Contreras; Francesca Polverino; Kushagra Gupta; Katherine L Taylor; Emer Kelly; Victor Pinto-Plata; Miguel Divo; Naveed Ashfaq; Hans Petersen; Barry Stripp; Aprile L Pilon; Yohannes Tesfaigzi; Bartolome R Celli; Caroline A Owen
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

5.  Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection.

Authors:  Shan-Ze Wang; Cynthia L Rosenberger; Yi-Xiao Bao; James M Stark; Kevin S Harrod
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

6.  Mycoplasma pneumonia: Clinical features and management.

Authors:  Surender Kashyap; Malay Sarkar
Journal:  Lung India       Date:  2010-04

Review 7.  Men and mice: Relating their ages.

Authors:  Sulagna Dutta; Pallav Sengupta
Journal:  Life Sci       Date:  2015-10-24       Impact factor: 5.037

8.  Protein 1 (Clara cell protein) serum levels in healthy subjects and patients with bacterial pneumonia.

Authors:  H Nomori; H Horio; G Fuyuno; R Kobayashi; S Morinaga; Y Hirabayashi
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

9.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Authors:  Claus F Vogelmeier; Gerard J Criner; Fernando J Martinez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolas Roche; Roberto Rodriguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

Review 10.  Mycoplasma pneumoniae: A Potentially Severe Infection.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.